University of Illinois at Chicago
Announcement of an Exempt Purchase
Life Technologies CorporationChicago, IL
- Amount: An estimated $250,000
- Terms: An estimated start date of 11/17/2020 through 6/30/2021
- Renewals: None
Summary
Vendors
1 total
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Tuesday, November 17, 2020
The University awarded a contract for reagents for assay validation.
Reagents for next generation sequencing for clinical assay validation. This clinical assay detects genetic mutation in tumor DNA of cancer patients which is a service we offer in the department of Pathology for cancer patients at UIC.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) We are performing clinical assay validation for a machine that was purchased from ThermoFisher Scientific. This machine is exclusively manufactured by ThermoFisher and the reagents are also manufactured by ThermoFisher. This clinical assay detects genetic mutation in tumor DNA of cancer patients which is a service we offer in the department of Pathology for cancer patients at UIC.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.
